Inhibiting Chk1 and Chk2, highly conserved serine/threonine kinases and key downstream targets of ATR and ATM, respectively, could disrupt the initiation of G1/S and G2/M checkpoints, impair DNA repair mechanisms and promote apoptosis in tumor cells [9,105]. The gene discussed is CHEK2; the disease is neoplasm.